Related Experiment Video
Updated: May 18, 2026
09:54
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
[HIV infection : chronic disease with comorbidities]
1Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Pettenkoferstr. 8a, 80336, München, Deutschland. johannes.bogner@med.uni-muenchen.de
Der Internist
|September 19, 2012
Summary
Managing comorbidities is crucial for long-term human immunodeficiency virus (HIV) treatment and prognosis. Addressing cardiovascular risks, viral hepatitis, kidney disease, and bone health improves patient outcomes.
Area of Science:
- Infectious Diseases
- Internal Medicine
- Gerontology
Context:
- Long-term human immunodeficiency virus (HIV) treatment requires managing comorbidities.
- Antiviral therapies, while effective, can contribute to disease pathogenesis and adverse reactions.
- HIV specialists need comprehensive internal medicine skills or collaborative networks.
Purpose:
- To highlight the growing importance of comorbidities in HIV management.
- To outline key comorbidities and their management strategies in HIV-infected individuals.
- To emphasize the evolving role of HIV clinicians as internists.
Summary:
- Cardiovascular risk factors, including elevated LDL cholesterol from antiviral treatment, require management via therapy adjustment or lipid-lowering agents.
- Other significant comorbidities include viral hepatitis B/C, nephropathy, and decreased bone mineral density.
- Preventive care, including vaccination and screening for non-HIV associated cancers, is essential.
Impact:
- Improved long-term prognosis and quality of life for individuals with HIV.
- Enhanced understanding of the multifaceted nature of HIV care beyond viral suppression.
- Guidance for clinicians on comprehensive management of HIV-related and unrelated conditions.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation